2013
DOI: 10.1016/j.clindermatol.2013.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Pemphigus: Associations and management guidelines: Facts and controversies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
75
0
9

Year Published

2015
2015
2019
2019

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 75 publications
(85 citation statements)
references
References 55 publications
1
75
0
9
Order By: Relevance
“…Treatment of PV with other methods includes the use of biological agents (rituximab, intravenous immunology therapy), plasmapheresis, and combination of tetracycline and nicotinamide. 2,3 There is no standard guidance for treatment of PV. Strowd et al conducted a study to establish algorithm in treatment of PV.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Treatment of PV with other methods includes the use of biological agents (rituximab, intravenous immunology therapy), plasmapheresis, and combination of tetracycline and nicotinamide. 2,3 There is no standard guidance for treatment of PV. Strowd et al conducted a study to establish algorithm in treatment of PV.…”
Section: Discussionmentioning
confidence: 99%
“…PV can be triggered by several factors such as psychological stress, drugs, radiation, diet (plant from genus Allium), surgical procedures, human herpes virus type 8 (HHV-8), pesticide, and pregnancy. [1][2][3][4] Corticosteroids are a drug of choice in treatment of PV, which can be used systemically or locally. 2,3 Corticosteroids can cause several side effects like hyperglycemia, skin atrophy, osteoporosis, muscle atrophy, eye cataracts, glaucoma, increase of blood pressure, delay in wound healing, cushingoid changes, peptic ulcers, adrenal suppression, and psychiatric effects.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…6 Topical treatments of corticosteroid can speed up reepithelialization of pemphigus lesions include epidermal growth and decrease disease progression and persistently decreased desmoglein-reactive antibody titer. 7 The treatment of PV patient requires long term use of immunosuppressant agents. Here in our case, the patient was treated for almost a year.…”
Section: Discussionmentioning
confidence: 99%
“…La mayoría de los procesos precisa inmunosupresión sistémica mantenida y es necesario el tratamiento de la enfermedad de base 8 . La afectación oral, que suele ser el signo inicial más temprano, también suele ser la más resistente al tratamiento.…”
Section: Beatriz García-bracamonteunclassified